Llwytho...
Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China
BACKGROUND: Colistin is being administered as last-line therapy for patients that have failed to respond to other available antibiotics that are active against Escherichia coli. The underlying mechanisms of colistin resistance and heteroresistance remain largely uncharacterized. The present study in...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Infect Drug Resist |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7553605/ https://ncbi.nlm.nih.gov/pubmed/33116674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S273784 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|